Not yet recruitingInterventionalNot ApplicableLast updated Aug 13, 2026

Effect of Citicoline on Neurological Severity Score and Cerebral Doppler Resistive Index in Neonatal Hypoxic Ischemic Encephalopathy: A Randomized Control Trial

Overview

ClinicalTrials.gov ID: NCT07763145
Lead Sponsor: Khyber Girls Medical CollegeOTHER
Brief Summary: To determine the efficacy of citicoline in improving cerebral blood flow parameters and neurological status among neonates with hypoxic-ischemic encephalopathy using Doppler resistive index and Sarnat-Sarnat score after 72 hours of therapy.
Study Type: Interventional

Status

Study Record Dates

NCT06522581Recruiting

Role of Citicoline in Treatment of Neonates With Hypoxic Ischemic Encephalopathy

NCT03181646Unknown status

Role of Citicoline in Treatment of Newborns With Hypoxic Ischemic Encephalopathy

NCT03949049Recruiting

Citicoline as Neuroprotector in Neonates Exposed to Hypoxia

NCT06855108Recruiting

Caffeine for Hypoxic Ischemic Encephalopathy

NCT01059461Completed

Study of Cerebrolysin for Treatment of Infants With History of Neonatal Hypoxic Ischemic Encephalopathy

NCT03966170Recruiting

Citicoline as Neuroprotector in Preterm